NCT00495417View on ClinicalTrials.gov

Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
Alzheimer's Disease
Interventions
BIOLOGICAL

AFFITOPE AD01

s.c. injection

BIOLOGICAL

AFFITOPE AD01 adjuvanted

s.c. injection

Trial Locations (1)

1090

Department of Clinical Pharmacology, Medical University of Vienna, Vienna

All Listed Sponsors
lead

Affiris AG

INDUSTRY

NCT00495417 - Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter